A pyrrole-biphenyl derivative compound, a preparation method thereof and application thereof in pharmacy
By developing pyrrolobenzyl derivatives, the shortcomings of existing SGLT-2 inhibitors in terms of specificity and safety in the treatment of tumors and non-alcoholic liver disease have been addressed, achieving highly efficient SGLT-2 inhibition and broad drug application, especially providing a new treatment strategy in the field of non-alcoholic liver disease.
Patent Information
- Application Number
- CN202510709332.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-29
- Publication Date
- 2026-06-09
- Estimated Expiration
- 2045-05-29
AI Technical Summary
Existing SGLT-2 inhibitors have insufficient specificity, efficacy, and safety in the treatment of cancer and non-alcoholic liver disease, and the optimal usage regimen and combination therapy strategy are not yet clear.
To develop a pyrrolobenzene derivative compound that competitively occupies the substrate binding site or binds to the allosteric site of SGLT-2 by mimicking the glucose conformation, thereby blocking glucose transport function and inhibiting sodium-glucose cotransport activity, and to design it into various drug formulations to enhance targeting and metabolic stability.
This compound exhibits highly potent SGLT-2 inhibitory activity with an IC50 value ranging from 15 to 105 nM. It possesses favorable pharmaceutical properties and safety profile, making it suitable for various drug formulations, particularly tablets, capsules, and injections. It is applicable to the treatment of a variety of diseases related to SGLT-2 activity or expression levels, and shows great therapeutic potential, especially in the field of non-alcoholic liver disease.
Smart Images

Figure CN120574217B_ABST
